Tularemia: emergence/re-emergence

被引:130
作者
Petersen, JM [1 ]
Schriefer, ME [1 ]
机构
[1] Ctr Dis Control & Prevent, Bacterial Zoonoses Branch, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO 80522 USA
关键词
tularemia; zoonosis; factors of emergence; Francisella tularensis;
D O I
10.1051/vetres:2005006
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Francisella tularensis is a gram-negative coccobacillus and the etiologic agent of the zoonotic disease tularemia. First described in 1911 in Tulare County, California, it has since been reported throughout the Northern Hemisphere, with natural infections reported among an unusually wide range of vertebrates and invertebrates. In recent years, tularemia has emerged in new geographic locations, populations, and settings. This review will serve to highlight mechanisms contributing to the recent emergence of tularemia as well as a repertoire of diagnostic tools useful for detecting and diagnosing disease.
引用
收藏
页码:455 / 467
页数:13
相关论文
共 71 条
[11]   EVALUATION OF A SAFRANIN-O-STAINED ANTIGEN MICROAGGLUTINATION TEST FOR FRANCISELLA-TULARENSIS ANTIBODIES [J].
BROWN, SL ;
MCKINNEY, FT ;
KLEIN, GC ;
JONES, WL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (02) :146-148
[12]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P688
[13]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P182
[14]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P618
[15]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P537
[16]  
CHU MC, 2003, MANUAL CLIN MICROBIO, P789
[17]   Characterization of two unusual clinically significant Francisella strains [J].
Clarridge, JE ;
Raich, TJ ;
Sjosted, A ;
Sandstrom, G ;
Darouiche, RO ;
Shawar, RM ;
Georghiou, PR ;
Osting, C ;
Vo, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) :1995-2000
[18]   Threats in bioterrorism I: CDC category A agents [J].
Darling, RG ;
Catlett, CL ;
Huebner, KD ;
Jarrett, DG .
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2002, 20 (02) :273-+
[19]   Genotyping of Francisella tularensis strains by pulsed-field gel electrophoresis, amplified fragment length polymorphism fingerprinting, and 16S rRNA gene sequencing [J].
Del Blanco, NG ;
Dobson, ME ;
Vela, AI ;
De La Puente, VA ;
Gutiérrez, CB ;
Hadfield, TL ;
Kuhnert, P ;
Frey, J ;
Domínguez, L ;
Ferri, EFR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) :2964-2972
[20]  
DELUCO F, 1998, 10 REUN SOC ESP AN P